Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) fell 4.2% in the morning session after the company reported underwhelming third-quarter 2025 financial results. The ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and argenex SE (ARGX). But which of these two companies is the best option for those looking for ...

Vijay K Iyengar, the EVP of $INCY, sold 2,682 shares of the company on 07-03-2025 for an estimated $182,805. We received data on the trade from a recent SEC filing ...

We recently published Wall Street Can’t Keep up With These 10 Crushing Stocks; 6 at Fresh Record Highs. Incyte Corp. (NASDAQ:INCY) is one of the best-performing on Monday. Incyte extended its winning ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Incyte (INCY), which belongs to the Zacks ...

We recently published 11 Best Cancer Stocks to Buy Right Now. Incyte Corporation stands fourth on our list. Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company focused on cancer and ...

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Incyte (INCY) and Genmab AS Sponsored ADR (GMAB). But which of these two stocks presents investors ...